PRIMARY STUDY
Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies
Key Findings: The authors conclude that the ECS may be altered in humans with ASD.
Type of Study: Clinical Meta-analysis
Study Result: Inconclusive
Study Location(s): Canada
Year of Pub: 2021
Cannabinoids Studied: Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG)
Phytocannabinoid Source: Not Applicable
